- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01353560
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study 1-Survey
12. juni 2017 opdateret af: Julie E. Buring, Brigham and Women's Hospital
Despite widespread and growing popularity of complementary and alternative medicine (CAM) in the US, there currently exist significant gaps in our knowledge regarding CAM use, clinical effectiveness, safety and cost- effectiveness.
With previous funding support from NCCAM, the Harvard Medical School (HMS) Osher Research Center established and trained a multidisciplinary integrative team of CAM and conventional providers to work collaboratively to provide state-of-the-art "integrative care" in a coordinated and individualized fashion.
The Osher Integrative Care Center (OCC) was opened in fall 2007, physically located within the Ambulatory Care Center of the Brigham and Women's Hospital (BWH) at 850 Boylston Street in Chestnut Hill, MA.
The focus of this survey study is to characterize the decision-making process of both patients and conventional providers with respect to communication about and referral to an integrative care team in an academic hospital outpatient setting.
Studieoversigt
Status
Afsluttet
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
1509
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Massachusetts
-
Chestnut Hill, Massachusetts, Forenede Stater, 02467
- Osher Clinical Center at Brigham and Women's Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
21 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
- All new patients coming into the Osher Clinical Center (OCC) for any medical reason.
- All physicians in the 5 included departments/divisions (Women's Health, Orthopedics, Obstetrics and Gynecology, General Medicine, and Rheumatology) are eligible to participate in the survey. Other BWH physicians whom OCC patients have identified as their referring doctors and given us permission to contact, will also be eligible to participate in the survey.
Beskrivelse
Inclusion Criteria:
- New patient coming into Osher Clinical Center for any medical reason.
- Physician affiliated with any of included division/department (see above).
Exclusion Criteria:
- Patient has been seen at Osher Clinical Center within past 3 months for any reason.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
New patients of Osher Clinical Center
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Characterization of decision-making process for patients of CAM therapies and conventional providers
Tidsramme: 3.5 years
|
Surveys will be sent to: 1) 1500 consecutive new patients seen at the OCC over 3.5 years, to characterize the chief complaints; their medical history; referral sources; communication with their physicians; barriers to use of CAM; views regarding and previous use of CAM; and expectations for CAM therapy as adjuncts to their conventional care; 2) 300 BWH physicians from five divisions (Women's Health, Orthopedics, Obstetrics and Gynecology, General Medicine, and Rheumatology) most likely to refer to the OCC, to assess their use of, feelings about, and knowledge of CAM.
|
3.5 years
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Julie E Buring, ScD, Brigham and Women's Hospital
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. maj 2011
Primær færdiggørelse (Faktiske)
1. oktober 2014
Studieafslutning (Faktiske)
1. oktober 2014
Datoer for studieregistrering
Først indsendt
12. maj 2011
Først indsendt, der opfyldte QC-kriterier
12. maj 2011
Først opslået (Skøn)
13. maj 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
14. juni 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
12. juni 2017
Sidst verificeret
1. juni 2017
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 1R01AT005065-01A1-1
- 1R01AT005065-01A1 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Lægebehandling
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
The Lymphoma Academic Research OrganisationNovartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
The Touro College and University SystemAktiv, ikke rekrutterendeMedical School Syndrome | Mind Body AwarenessForenede Stater
-
Universitaire Ziekenhuizen KU LeuvenAfsluttetTest-gentest pålidelighed | Gyldighed | Biodex Medical Systems III Dynamometer | Eksperimentel måling af knæforlængelsestyrkeBelgien
-
Nantes University HospitalIMT Mines Albi - France (https://www.imt-mines-albi.fr/)UkendtEmergency Medical Service Communication Systems, Health Care
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Central Denmark RegionAfsluttetEmergency Medical Dispatch Center | Videostreaming | Nødopkald | Præhospital akutmedicinDanmark